These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25070599)

  • 21. A multilevel analysis on the determinants of regional health care expenditure: a note.
    López-Casasnovas G; Saez M
    Eur J Health Econ; 2007 Mar; 8(1):59-65. PubMed ID: 17186198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between health expenditures and the age structure of the population in OECD countries.
    O'Connell JM
    Health Econ; 1996; 5(6):573-8. PubMed ID: 9003943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An empirical analysis of US and Japanese health insurance using age-period-cohort decomposition.
    Fukuda K
    Health Econ; 2007 May; 16(5):475-89. PubMed ID: 17039572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-care expenditure and health policy in the USA versus other high-spending OECD countries.
    Lorenzoni L; Belloni A; Sassi F
    Lancet; 2014 Jul; 384(9937):83-92. PubMed ID: 24993914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical expenditures as a correlate of population health in industrialized nations.
    Liu L; Cline RR; Schondelmeyer SW; Schommer JC
    Ann Pharmacother; 2008 Mar; 42(3):368-74. PubMed ID: 18272699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The roles of preventive and curative health care in economic development.
    Wang F
    PLoS One; 2018; 13(11):e0206808. PubMed ID: 30403708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The best care money can buy? The U.S. delights in its medical technology, and pays a premium for it, but studies show other countries beat us in outcomes, values.
    Becker C
    Mod Healthc; 2004 Aug; 34(32):26-9. PubMed ID: 15352766
    [No Abstract]   [Full Text] [Related]  

  • 28. Insurance effects on US medical spending (1960-1993).
    Peden EA; Freeland MS
    Health Econ; 1998 Dec; 7(8):671-87. PubMed ID: 9890329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The determinants of health care expenditure: testing pooling restrictions in small samples.
    Herwartz H; Theilen B
    Health Econ; 2003 Feb; 12(2):113-24. PubMed ID: 12563659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22582452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22619775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. More Health Expenditure, Better Economic Performance? Empirical Evidence From OECD Countries.
    Wang F
    Inquiry; 2015; 52():. PubMed ID: 26310501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between per capita income and diffusion of medical technologies.
    Slade EP; Anderson GF
    Health Policy; 2001 Oct; 58(1):1-14. PubMed ID: 11518598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fiscal rules, powerful levers for controlling the health budget? Evidence from 32 OECD countries.
    Schakel HC; Wu EH; Jeurissen P
    BMC Public Health; 2018 Mar; 18(1):300. PubMed ID: 29490651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global spending on prescription drugs to top $1 trillion by 2017, report says.
    McCarthy M
    BMJ; 2013 Nov; 347():f6997. PubMed ID: 24264569
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost Sharing, Health Care Expenditures, and Utilization: An International Comparison.
    Perkowski P; Rodberg L
    Int J Health Serv; 2016; 46(1):106-23. PubMed ID: 26545706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-offsets of prescription drug expenditures: data analysis via a copula-based bivariate dynamic hurdle model.
    Deb P; Trivedi PK; Zimmer DM
    Health Econ; 2014 Oct; 23(10):1242-59. PubMed ID: 23956147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do health expenditures 'catch-up'? Evidence from OECD countries.
    Narayan PK
    Health Econ; 2007 Oct; 16(10):993-1008. PubMed ID: 17238220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is technology still a major driver of health expenditure in the United States? Evidence from cointegration analysis with multiple structural breaks.
    Murthy VNR; Ketenci N
    Int J Health Econ Manag; 2017 Mar; 17(1):29-50. PubMed ID: 28477293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health care expenditures and GDP in Latin American and OECD countries: a comparison using a panel cointegration approach.
    Rodríguez AF; Nieves Valdés M
    Int J Health Econ Manag; 2019 Jun; 19(2):115-153. PubMed ID: 30267372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.